We publish routine updates to performance data for the assessment of clinical trials and established medicines within 15 days of the end of each month. This is to help improve the predictability of decision making in applications for clinical trials, marketing authorisations and variations to existing approvals.
Published 'Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 January 2024)' & 'Clinical Trials Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (February 2023 January 2024)'
Published 'Performance Metrics January 2023 December 2023: Assessment of New Marketing Authorisation Applications and Variations' and 'Clinical Trials Performance Metrics: December 2022 - December 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments'
Published 'Clinical Trials Performance Metrics: December 2022 - November 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments' and 'Performance Metrics January 2023 November 2023: Assessment of New Marketing Authorisation Applications and Variations'.
Published 'Clinical Trials Performance Metrics: November 2022 - October 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments' & 'Performance Metrics January 2023 October 2023: Assessment of New Marketing Authorisation Applications and Variations'
Published 'Clinical Trials Performance Metrics: October 2022 -September 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments' and 'Performance Metrics January 2023 September 2023: Assessment of New Marketing Authorisation Applications and Variations'.
Published 'Clinical Trials Performance Metrics: September 2022 - August 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments' and 'Performance Metrics January 2023 August 2023: Assessment of New Marketing Authorisation Applications and Variations'
Published 'Clinical Trials Performance Metrics: August 2022 to September 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments'
Published 'Clinical Trials Performance Metrics: July 2022 - July 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments' & 'Performance Metrics January 2023 June 2023: Assessment of New Marketing Authorisation Applications and Variations'
Added: Clinical Trials Performance Metrics: July 2022 - June 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments - file attachment & Performance Metrics January 2023 June 2023: Assessment of New Marketing Authorisation Applications and Variations - file attachment
Added 'Clinical Trials Performance Metrics: June 22 - May 23' and 'Performance Metrics January 23 May 23: Assessment of New Marketing Authorisation Applications and Variations'
Added latest performance metrics for 'Assessment of Clinical TrialAuthorisation Applications and Substantial Amendments' and 'Assessment of New Marketing Authorisation Applications and Variations'
First published.